Health Trials

Adenosine Pre-Medication in Primary Percutaneous Coronary Intervention

ConditionsST-Segment Elevation Myocardial Infarction (STEMI)No-Reflow PhenomenonCoronary Slow FlowAcute Myocardial Infarction
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-80
SponsorNational Institute of Cardiovascular Diseases, Pakistan

About this trial

Primary objective of the study is to evaluate the impact of adenosine pre-medication on incidence of slow flow/no-reflow after primary percutaneous coronary intervention.

Eligibility criteria

Qualifiers

All patients with acute STEMI undergoing primary PCI

Patients of either sex, ≥18 years of age.

Disqualifiers

STEMI patients with cardiogenic shock at presentation

Patients with heart block

Allergy to adenosine

Patients refuse to give consent for participation

Trial design

Treatments tested in this trial

  • Adenosine pre-medication
  • Standard care

Treatment groups

1,148 Participants
are divided into 2 treatment groups

Sponsors and collaborators

National Institute of Cardiovascular Diseases, Pakistan

Lead sponsor

Source ClinicalTrials.gov